30. Virmani MA, Biselli R, Spadoni A, Rossi S, et al. Protective Actions Of L-Carnitine And Acetyl-L-Carnitine On The Neurotoxicity Evoked By Mitochondrial Uncoupling Or Inhibitors. Pharmacol Res 1995;32(6):383-389.

31. Famularo G, Moretti S, Marcellini S, Trinchieri V, et al. Acetyl-Carnitine Deficiency In AIDS Patients With Neurotoxicity On Treatment With Antiretroviral Nucleoside Analogues. AIDS 1997;11(2):185-190.

32. De Simone C, Famularo G, Tzantzoglou S, Trinchieri V, et al. Carnitine Depletion In Peripheral Blood Mononuclear Cells From Patients With AIDS: Effect Of Oral L-Carnitine. AIDS 1994;8(5):655-660.

33. Skurnick JH, Bogden JD, Baker H, Kemp FW, et al. Micronutrient Profiles In HIV-1-Infected Heterosexual Adults. J AIDS 1996;12(1):75-83.

34. Bogden JD, Baker H, Frank O, Perez G, et al. Micronutrient Status And Human Immunodeficiency Virus (HIV) Infection. Ann NY Academy Science 1990;:189-195.

35. Dalakas MC, Leon-Monzon ME, Bernardini I, et al. Zidovudine-Induced Mitochondrial Myopathy Is Associated With Muscle Carnitine Deficiency And Lipid Storage. Ann Neurol 1994;35(4):482-487.

36. Moretti S, Alesse E, DiMarzio, et al. Effect Of L-Carnitine On Human Immunodeficiency Virus-1 Infection-Associated Apoptosis: A Pilot Study. Blood 1998;91:3817-3824.

37. DeSimone C, Tzantzoglou S, Famularo G, et al. High Dose L-Carnitine Improves Immunologic And Metabolic Parameters In AIDS Patients. Immunopharmacol Immunotoxicol 1993;15:1-12. 

38. Scarpini E, Sailotto G, Baron P, et al. Effect Of Acetyl-L-Carnitine In The Treatment Of Painful Peripheral Neuropathies In HIV+ Patients. J Peripher Nerv Syst 1997;2:227-9.

39. Mingrone G, Greco AV, Capristo E, et al. L-Carnitine Improves Glucose Disposal In Type 2 Diabetic Patients. J Am Coll Nutr 1999;18:77-82.

40. Carnitor® Web Site. Sigma-Tau Pharmaceuticals, Inc. 

41. Millington DS. Dietary Supplement L-Carnitine: Analysis Of Different Brands To Determine Bioavailability And Content. Clin Research Reg Affairs 1993;10(2):71-80.

42. Carnitor® (levocarnitine). Physicians’ Desk Reference. Montvale, NJ: Medical Economics Company 2001;55:3045-9. 

43. Fuhrmann M. Stereospecific Purity Of L-Carnitine And Analytical Control Of Deleterious D-Carnitine. In: L-Carnitine, A 'Vitamin-Like Substance' For Functional Food. Proceedings Of The Symposium On L-Carnitine, April 28 to May 1, 2000, Zermatt, Switzerland. Walter P, Schaffhauser AO, Editors. Ann Nutr Metab 2000;44(2):80. 

44. Lonza L-Carnitine web site. 

45. Carnitine And Acetylcarnitine. Treatment Information Sheet. New York, NY:Direct AIDS Alternative Information Resources (DAAIR);1997:1-6. 

46. Lyons L. L-acetylcarnitine And L-carnitine. Toronto: CATIE; Winter 2000. 

47. Benvenga S, Lakshmanan M, Trimarchi F. Carnitine Is A Naturally Occurring Inhibitor Of Thyroid Hormone Nuclear Uptake. Thyroid 2000;10:1043-1050.

48. Lichtner H. RD, MA, LDN, Jemsek Clinic, Charlotte, NC. Program Spotlight Survey 5 June 2001.

49. Famularo G, De Simone C, Cifone G. Carnitine Stands On Its Own In HIV Infection Treatment. Arch Intern Med 1999;159:1143-1144.